- CMS has removed 285 procedures from Medicare’s Inpatient-Only (IPO) list in 2026, with the list set to be eliminated by 2028 – accelerating the shift to outpatient and ambulatory surgery center (ASC) settings.
- Reliance on spreadsheets, reference documents, and institutional knowledge makes it difficult to apply changing CMS and commercial payer requirements consistently.
- Effective data governance gives scheduling, utilization management, clinical, and revenue cycle teams a shared framework for evaluating procedures.
- Embedding procedural guidance into existing workflows can reduce scheduling errors, administrative burden, and reimbursement risk.
Medicare’s Inpatient-Only (IPO) list has long determined where certain surgical procedures can be performed and reimbursed. As the Centers for Medicare & Medicaid Services (CMS) continues to remove procedures from the list, hospitals face a growing operational challenge: identifying the appropriate care setting while balancing reimbursement, compliance, operational efficiency, and patient safety.
CMS removed 285 procedures from the IPO List in 2026 and proposes removing another 638 services across 11 clinical families in 2027, with the list targeted for elimination by 2028.
While advances in surgical techniques, anesthesia, and postoperative care have made outpatient treatment appropriate for more procedures, CMS and payers continue encouraging care in lower-cost settings when clinically appropriate.
As a result, surgical scheduling decisions now require teams to weigh a growing number of clinical, financial, and regulatory factors, including:
- CMS reimbursement policies
- Commercial payer requirements
- Patient-specific clinical factors
- Documentation requirements
- Organizational protocols
The core challenge is operationalizing policy changes consistently across thousands of procedures, payer scenarios, and patient circumstances. That includes maintaining accurate HCPCS and CPT® mappings so teams have reliable information when scheduling care.
A procedure that was historically defaulted to inpatient status may now require additional review. Without a standardized process to evaluate these cases and maintain procedural data, different teams may reach different conclusions about the same procedure.
What’s changing for the IPO List in 2027?
Unlike the first wave of removed services, the proposed changes for CY 2027 span 11 clinical families, including digestive, respiratory, urinary, endocrine, and maternity care.
CMS says advances in medical practice are allowing more procedures to be performed safely in outpatient settings with shorter recovery times. Removing these services from the IPO List would allow Medicare to pay for them in the hospital outpatient setting when clinically appropriate, giving physicians greater flexibility in determining site of service.
For health systems, however, greater flexibility also increases the importance of having current, governed procedure data available when cases are scheduled.
The financial risk of choosing the wrong surgical setting
One of the biggest financial risks associated with the IPO phaseout is a preventable scheduling error.
When procedures are scheduled in the wrong setting, organizations may face:
- Revenue leakage from claim denials, delayed reimbursement, or total-loss cases
- Additional documentation requests and peer-to-peer reviews
- Delayed patient care from scheduling disruptions
Many organizations still rely on spreadsheets, payer websites, reference documents, and institutional knowledge to determine the correct care setting. These disconnected resources make it difficult to keep guidance current and apply requirements consistently across the enterprise.
And the impact isn’t limited to reimbursement. Teams also spend valuable time researching requirements, resolving discrepancies, and correcting avoidable errors instead of focusing on patient care and higher-value initiatives.
Patients and care teams can feel the consequences as well. Incorrect placement may introduce scheduling delays, repeated documentation requests, and unnecessary administrative friction before a procedure can move forward.
Why data governance matters
Inconsistent or outdated surgical data can lead different departments to apply the same requirements in different ways. Effective governance provides a common operating framework across scheduling, utilization management, revenue cycle, and clinical teams. It establishes how procedures should be evaluated, coded, documented, and aligned with payer and regulatory requirements.
An effective governance strategy should include:
- Standardized decision criteria for care-setting and prior authorization decisions
- Clearly defined stakeholder responsibilities
- Ongoing monitoring of payer and regulatory policy changes
- Consistent documentation practices
- Escalation pathways for complex cases
Together, these capabilities help teams make more consistent decisions, submit cleaner prior authorization requests, and resolve complex cases before they create downstream problems.
Building a strategy that can scale
Governance is only effective when teams can apply it in their daily work. As procedures continue to leave the IPO list, health systems need an approach that can absorb ongoing regulatory and payer changes without adding more administrative burden.
Embedding decision support directly into scheduling and clinical workflows gives teams timely guidance on whether a procedure is appropriate for the inpatient, outpatient, or ASC setting. It also makes current coding and payer information available at the point of decision, including when CMS and commercial expectations diverge.
Looking ahead
The IPO phaseout reflects a broader shift in how surgical care is delivered and reimbursed. For hospital leaders, success will depend less on reacting to each procedure removed from the list and more on building the infrastructure needed to manage continuous change.
To stay ahead of these changes, health systems should focus on three areas:
Govern surgical data
Maintain a standardized surgical dictionary across the organization to support more consistent decision-making.
Keep guidance current
Stay aligned with changing coding and payer requirements.
Validate earlier
Surface site-of-care guidance at the point of entry so potential issues can be addressed before they create downstream revenue cycle problems.
Together, these practices can help organizations reduce rework and denials, protect revenue, and adapt as CMS and payer requirements continue to evolve.
Need help aligning your surgical workflows with the right care setting as the IPO phaseout continues? Connect with an IMO Health expert.
CPT is a registered trademark of the American Medical Association. All rights reserved.
